Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

$ API Reference Price

$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Nad+, 53-84-9, Coenzyme i, Beta-nad, Codehydrase i, Codehydrogenase i

Molecular Formula

C₂₁H₂₇N₇O₁₄P₂

Molecular Weight

663.4 g/mol

InChI Key

BAWFJGJZGIEFAR-NNYOXOHSSA-N

A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed)

1 2D Structure

M041

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate

2.1.2 InChI

InChI=1S/C21H27N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37)/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1

2.1.3 InChI Key

BAWFJGJZGIEFAR-NNYOXOHSSA-N

2.1.4 Canonical SMILES

C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)([O-])OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)C(=O)N

2.1.5 Isomeric SMILES

C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)C(=O)N

2.2 Synonyms

2.2.1 MeSH Synonyms

1. Adenine Dinucleotide, Dihydronicotinamide

2. Coenzyme I

3. Dihydronicotinamide Adenine Dinucleotide

4. Dinucleotide, Dihydronicotinamide Adenine

5. Dinucleotide, Nicotinamide-adenine

6. Diphosphopyridine Nucleotide

7. Dpn

8. Nad

9. Nadh

10. Nicotinamide Adenine Dinucleotide

11. Nicotinamide-adenine Dinucleotide

12. Nucleotide, Diphosphopyridine

2.2.2 Depositor-Supplied Synonyms

1. Nad+

2. 53-84-9

3. Coenzyme I

4. Beta-nad

5. Codehydrase I

6. Codehydrogenase I

7. Nicotinamide Adenine Dinucleotide

8. Beta-nad+

9. Cozymase I

10. Diphosphopyridine Nucleotide

11. Beta-nicotinamide Adenine Dinucleotide

12. Beta-diphosphopyridine Nucleotide

13. Cozymase

14. Nicotinamide Dinucleotide

15. Co-i

16. Enzopride

17. Nad

18. Nadidum

19. Nad Zwitterion

20. Oxidized Diphosphopyridine Nucleotide

21. Co-1

22. Pyridine, Nucleotide Diphosphate

23. Nicotineamide Adenine Dinucleotide

24. Nicotinamide-adenine Dinucleotide

25. Beta-dpn

26. Adenine-nicotinamide Dinucleotide

27. Codehydrogenase

28. Nadidum [inn-latin]

29. Nadida [inn-spanish]

30. Nicotinamide Adenine Dinucleotide Oxidized

31. Beta-diphosphopyridinenucleotide

32. Chebi:44215

33. Brn 3584133

34. Diphosphopyridine Nucleotide Oxidized

35. Nad Trihydrate

36. 3-carbamoyl-1-beta-d-ribofuranosylpyridinium Hydroxide, 5'-ester With Adenosine 5'-pyrophosphate, Inner Salt

37. Nad-oxidized

38. Nicotinamide Adenine Dinucleotide (nad)

39. Nicotinamide-adenine-dinucleotide

40. Mfcd00036253

41. Nsc 20272

42. Dpn-ox

43. .beta.-nad

44. 64417-72-7

45. Nad Lithium Salt

46. Endopride

47. Adenosine 5'-(trihydrogen Diphosphate), P'-5'-ester With 3-(aminocarbonyl)-1-beta-d-ribofuranosylpyridinium Hydroxide, Inner Salt

48. Dpn+

49. Nad+, Free Acid

50. Nadida

51. Adenosine 5'-(trihydrogen Diphosphate), P'-5'-ester With 3-(aminocarbonyl)-1-beta-d-ribofuranosylpyridinium, Inner Salt

52. 0u46u6e8uk

53. 1-((2r,3r,4s,5r)-5-((((((((2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-3-carbamoylpyridin-1-ium

54. Nsc-20272

55. Nadide [usan:inn:ban:jan]

56. Pyridinium, 3-carbamoyl-1-beta-d-ribofuranosyl-, Hydroxide, 5'-ester With Adenosine 5'-5'-(trihydrogen Pyrophosphate), Inner Salt

57. Einecs 200-184-4

58. Unii-0u46u6e8uk

59. Nadlithiumsalt

60. Nsc20272

61. Cas-53-84-9

62. B-nicotinamide Adenine Dinucleotide

63. Ncgc00016240-01

64. B-dpn

65. B-nad

66. Beta-nicotinamide Adenine Dinucleotide Hydrate

67. [adenylate-32-p]-nad

68. Carbonyl [14c] Nad+

69. Ec 200-184-4

70. Nad, Grade I, Free Acid

71. [adenylate-32-p]-nad+

72. Dsstox_cid_25236

73. Dsstox_rid_80768

74. Nad, Grade Ii, Free Acid

75. Dsstox_gsid_45236

76. 5-26-16-00399 (beilstein Handbook Reference)

77. Schembl131544

78. Spectrum1500419

79. Pyridine Nucleotide Diphosphate

80. Gtpl2451

81. Chembl1234613

82. Dtxsid2045236

83. Hms500j11

84. Nicotinamide Adinine Dinucleotide

85. [14c] Nad+

86. [32p] Nad+

87. Bdbm213227

88. Hms2091h06

89. Hms2097e04

90. Hms3714e04

91. Pharmakon1600-01500419

92. Ex-a3535

93. Hy-b0445

94. Tox21_110321

95. Ccg-40114

96. Nsc757121

97. S2518

98. Akos015892319

99. Beta-nicotinamide Adenine Din-ucleotide

100. Db14128

101. Nsc-757121

102. .beta.-nicotinamide Adenine Dinucleotide

103. Ncgc00178839-01

104. Ncgc00178839-02

105. Ncgc00178839-03

106. Ncgc00178839-08

107. [[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2r,3s,4r,5r)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl Phosphate

108. Adenosine 5'-(trihydrogen Diphosphate), 5'-5'-ester With 3-(aminocarbonyl)-1-beta-d-ribofuranosylpyridinium, Hydroxide, Inner Salt

109. As-14652

110. Sbi-0051451.p003

111. Ab00513910

112. D0919

113. Beta-nicotinamide Adenine Dinucleotide, Reduced

114. Ab00052048_03

115. Beta-nicotinamide Adenine Dinucleotide Trihydrate

116. Beta-nicotinamide Adenine Dinucleotide Hydrate, >=99%

117. Q12499775

118. F45c0d6c-da87-47be-9975-7a5de9ccb985

119. Beta-nicotinamide Adenine Dinucleotide Hydrate, >=95% (hplc)

120. Beta-nicotinamide Adenine Dinucleotide, Pkg Of 10 Mg (per Vial)

121. Beta-nicotinamide Adenine Dinucleotide, Pkg Of 20 Mg (per Vial)

122. Beta-nicotinamide Adenine Dinucleotide, Pkg Of 50 Mg (per Vial)

123. Beta-nicotinamide Adenine Dinucleotide Hydrate, >=98%, Bioultra, From Yeast

124. Beta-nicotinamide Adenine Dinucleotide Hydrate, Grade Aa-1, >=95% (hplc)

125. 3-carbamoyl-1-d-ribofuranosylpyridinium Hydroxide 5'-ester With Adenosine 5'-pyrophosphate

126. Beta-nicotinamide Adenine Dinucleotide Hydrate, Purified By Column Chromatography, >=99%

127. Beta-nicotinamide Adenine Dinucleotide Hydrate, Vetec(tm) Reagent Grade, >=96.5%

128. [(3s,2r,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl {[(3s,2r,4r,5r)-5-(3-carbamoylpyridyl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxyphosphoryl) Hydrogen Phosphate

129. [(3s,2r,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl {[(3s,2r,4r,5r)-5-(3-carbamoylpyridyl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxyphosphoryl)hydrogen Phosphate

130. [[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] [(2r,3s,4r,5r)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl Hydrogen Phosphate

131. 3-carbamoyl-1-beta-d-ribofuranosylpyridinium Hydroxide 5'-ester With Adenosine 5'-pyrophosphate Inner Salt

132. 3-carbamoyl-1-beta-delta-ribofuranosylpyridinium Hydroxide 5'-ester With Adenosine 5'-pyrophosphate Inner Salt

133. 3-carbamoyl-1-delta-ribofuranosylpyridinium Hydroxide 5'-ester With Adenosine 5'-pyrophosphate

134. Adenosine 5'-(trihydrogen Diphosphate), P'->5'-ester With 3-(aminocarbonyl)-1-beta-d-ribofuranosylpyridinium, Inner Salt

135. Adenosine 5'-(trihydrogen Diphosphate), P'.fwdarw.5'-ester With 3-(aminocarbonyl)-1-beta-d-ribofuranosylpyridinium, Inner Salt

136. Adenosine 5'-(trihydrogen Diphosphate-p-32p), P'>5'-ester With 3-(aminocarbonyl)-1-beta-d-ribofuranosylpyridinium, Inner Salt (9ci)

137. Beta-nicotinamide Adenine Dinucleotide Hydrate, >=96.5% (hplc), >=96.5% (spectrophotometric Assay), From Yeast

138. Beta-nicotinamide Adenine Dinucleotide Hydrate, Cell Culture Tested, >=96.5% (hplc), >=96.5% (spectrophotometric Assay), From Yeast

139. Beta-nicotinamide Adenine Dinucleotide Hydrate, Pharmagrade, Manufactured Under Appropriate Controls For Use As A Raw Material In Pharma Or Biopharmaceutical Production.

140. Beta-nicotinamide Adenine Dinucleotide Hydrate, Suitable For Manufacturing Of Diagnostic Kits And Reagents

141. Pyridinium, 3-carbamoyl-1-b-d-ribofuranosyl-, Hydroxide, 5'-5'-ester With Adenosine 5'-(trihydrogen Pyrophosphate), Inner Salt (8ci)

2.3 Create Date

2005-06-08

3 Chemical and Physical Properties

Molecular Formula	C₂₁H₂₇N₇O₁₄P₂
Molecular Weight	663.4 g/mol
XLogP3	-6
Hydrogen Bond Donor Count	7
Hydrogen Bond Acceptor Count	18
Rotatable Bond Count	11
Exact Mass	663.10912256 g/mol
Monoisotopic Mass	663.10912256 g/mol
Topological Polar Surface Area	321 Å²
Heavy Atom Count	44
Formal Charge	0
Complexity	1120
Isotope Atom Count	0
Defined Atom Stereocenter Count	8
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

Drugs in Development

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Find M041 manufacturers, exporters & distributors on PharmaCompass

M041

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 493

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

2DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?